Tags

Type your tag names separated by a space and hit enter

[Refractive benefit and incremental costs of LASIK: results of a cost benefit study in two universities' LASIK departments].
Klin Monbl Augenheilkd. 2003 May; 220(5):320-5.KM

Abstract

BACKGROUND

No data is available to date on the cost effectiveness of laser in situ keratomileusis (LASIK) with regard to the German-speaking health care system. Hence we compared the clinical outcome and cost data of two German LASIK centres in respect of procedure cost effectiveness from the patient perspective.

MATERIAL AND METHODS

A retrospective cohort study was implemented at the University Hospitals of Mainz and Mannheim. Data on refractive outcome were obtained from the LASIK centres' patient documentation, cost data on the surgery as well as on eyeglasses etc. before and after the surgery were obtained from patient interviews. The primary endpoint of this investigation was the individual incremental cost effectiveness ratio linking direct cost with the LASIK associated refractive gain.

RESULTS

Clinical and economical data of 178 patients (Mainz: 45, Mannheim 133) was evaluated. After biplanar simultaneous LASIK 71% (Mainz) and 73% (Mannheim) reported, that they did not need eyeglasses etc. any longer after surgery; 31% (Mainz) versus 13% (Mannheim) had to undergo LASIK re-treatment. Median direct cost for the surgery was reported to be 3000 euro; (Mainz) versus 3910 euro; (Mannheim); the corresponding LASIK associated refractive gain was +5.6 D (median Mainz) versus +4.2 D (median Mannheim), resulting in median incremental cost effectiveness ratios of 667 euro; (Mainz) versus 831 euro; (Mannheim) per gained refractive unit. This investment has to be related to median annual cost of 250 euro; for eyeglasses etc. before surgery and 0 euro; afterwards.

CONCLUSION

Depending on the performing surgical centre, German LASIK patients have to face a median investment of 667-831 euro; per gained refractive benefit unit. This incremental cost benefit ratio can be regarded as a surrogate parameter for comparison with alternative surgical or conservative treatment strategies in myopia.

Authors+Show Affiliations

Institut für Medizinische Biometrie, Epidemiologie und Informatik der Universität Mainz. krummi@imbei.uni-mainz.deNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
English Abstract
Journal Article
Multicenter Study

Language

ger

PubMed ID

12766820

Citation

Krummenauer, Frank, et al. "[Refractive Benefit and Incremental Costs of LASIK: Results of a Cost Benefit Study in Two Universities' LASIK Departments]." Klinische Monatsblatter Fur Augenheilkunde, vol. 220, no. 5, 2003, pp. 320-5.
Krummenauer F, Roden M, Knorz MC, et al. [Refractive benefit and incremental costs of LASIK: results of a cost benefit study in two universities' LASIK departments]. Klin Monbl Augenheilkd. 2003;220(5):320-5.
Krummenauer, F., Roden, M., Knorz, M. C., & Dick, H. B. (2003). [Refractive benefit and incremental costs of LASIK: results of a cost benefit study in two universities' LASIK departments]. Klinische Monatsblatter Fur Augenheilkunde, 220(5), 320-5.
Krummenauer F, et al. [Refractive Benefit and Incremental Costs of LASIK: Results of a Cost Benefit Study in Two Universities' LASIK Departments]. Klin Monbl Augenheilkd. 2003;220(5):320-5. PubMed PMID: 12766820.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Refractive benefit and incremental costs of LASIK: results of a cost benefit study in two universities' LASIK departments]. AU - Krummenauer,Frank, AU - Roden,Marco, AU - Knorz,Michael C, AU - Dick,H Burkhard, PY - 2003/5/27/pubmed PY - 2003/12/10/medline PY - 2003/5/27/entrez SP - 320 EP - 5 JF - Klinische Monatsblatter fur Augenheilkunde JO - Klin Monbl Augenheilkd VL - 220 IS - 5 N2 - BACKGROUND: No data is available to date on the cost effectiveness of laser in situ keratomileusis (LASIK) with regard to the German-speaking health care system. Hence we compared the clinical outcome and cost data of two German LASIK centres in respect of procedure cost effectiveness from the patient perspective. MATERIAL AND METHODS: A retrospective cohort study was implemented at the University Hospitals of Mainz and Mannheim. Data on refractive outcome were obtained from the LASIK centres' patient documentation, cost data on the surgery as well as on eyeglasses etc. before and after the surgery were obtained from patient interviews. The primary endpoint of this investigation was the individual incremental cost effectiveness ratio linking direct cost with the LASIK associated refractive gain. RESULTS: Clinical and economical data of 178 patients (Mainz: 45, Mannheim 133) was evaluated. After biplanar simultaneous LASIK 71% (Mainz) and 73% (Mannheim) reported, that they did not need eyeglasses etc. any longer after surgery; 31% (Mainz) versus 13% (Mannheim) had to undergo LASIK re-treatment. Median direct cost for the surgery was reported to be 3000 euro; (Mainz) versus 3910 euro; (Mannheim); the corresponding LASIK associated refractive gain was +5.6 D (median Mainz) versus +4.2 D (median Mannheim), resulting in median incremental cost effectiveness ratios of 667 euro; (Mainz) versus 831 euro; (Mannheim) per gained refractive unit. This investment has to be related to median annual cost of 250 euro; for eyeglasses etc. before surgery and 0 euro; afterwards. CONCLUSION: Depending on the performing surgical centre, German LASIK patients have to face a median investment of 667-831 euro; per gained refractive benefit unit. This incremental cost benefit ratio can be regarded as a surrogate parameter for comparison with alternative surgical or conservative treatment strategies in myopia. SN - 0023-2165 UR - https://www.unboundmedicine.com/medline/citation/12766820/[Refractive_benefit_and_incremental_costs_of_LASIK:_results_of_a_cost_benefit_study_in_two_universities'_LASIK_departments]_ L2 - https://www.thieme-connect.com/DOI/DOI?10.1055/s-2003-39424 DB - PRIME DP - Unbound Medicine ER -